Drug Chatter -- Tracking biopharma stock chatter

Profile for Atara Biotherapeutics, Inc. (ATRA)

« Back to company index

ATRA Chatter Timeline

Stock Ticker for ATRA

Most Active Tweeters for ATRA

UserTweets
@ConsumerFeed 7
@AmericanBanking 7
@JacobPlieth 6
@storminvestor 6
@TickerReport 6

Recent Tweets for ATRA

dispatchtribune @dispatchtribune
Carol Giltner Gallagher Sells 1,184 Shares of Atara Biotherapeutics, Inc. $ATRA Stock https://t.co/r3biKb7JQB
November 19th 2017, 5:11pm
TranscriptDaily @TranscriptDaily
Atara Biotherapeutics, Inc. $ATRA Director Carol Giltner Gallagher Sells 1,184 Shares of Stock https://t.co/rQOQS6xekd
November 19th 2017, 4:11pm
WatchlistN @WatchlistN
Christopher Haqq Sells 1,604 Shares of Atara Biotherapeutics, Inc. $ATRA Stock https://t.co/FUCoQpyYpY
November 19th 2017, 3:11pm
emq_news @emq_news
Gad Soffer Sells 7,000 Shares of Atara Biotherapeutics, Inc. $ATRA Stock https://t.co/cxkQuwcdjl
November 19th 2017, 11:11am
stocknewstimes @stocknewstimes
Gad Soffer Sells 7,000 Shares of Atara Biotherapeutics, Inc. $ATRA Stock https://t.co/FZKYc12RNR
November 19th 2017, 11:11am
dakotafinancial @dakotafinancial
Alps Advisors Inc. Has $498,000 Stake in Atara Biotherapeutics, Inc. $ATRA https://t.co/fLFbcvVrvW
November 19th 2017, 10:11am
ConsumerFeed @ConsumerFeed
Alps Advisors Inc. Has $498,000 Stake in Atara Biotherapeutics, Inc. $ATRA https://t.co/pUKowlJXEn
November 19th 2017, 10:11am
SleekMoneycom @SleekMoneycom
Atara Biotherapeutics $ATRA Earning Somewhat Positive Press Coverage, Analysis Shows https://t.co/lV7KrqN2sG
November 19th 2017, 7:11am
stocknewstimes @stocknewstimes
Atara Biotherapeutics $ATRA Earning Somewhat Positive Press Coverage, Analysis Shows https://t.co/iRZqOKoNcQ
November 19th 2017, 7:11am
SPNewsAnalysis @SPNewsAnalysis
Atara Biotherapeutics, Inc. $ATRA EVP Christopher Haqq Sells 1,604 Shares https://t.co/lylT06S2b8
November 19th 2017, 1:11am
storminvestor @storminvestor
Atara Biotherapeutics, Inc. $ATRA EVP Christopher Haqq Sells 1,604 Shares https://t.co/f7TzFqdnsy
November 19th 2017, 12:11am
storminvestor @storminvestor
Atara Biotherapeutics, Inc. $ATRA EVP Gad Soffer Sells 7,000 Shares of Stock https://t.co/uY9Kl94p12
November 18th 2017, 6:11pm
finboxio @finboxio
Seth Klarman owns Atara Biotherapeutics, Inc. $ATRA. Should you? Stock has nice upside https://t.co/AOwk0LkuTW https://t.co/TWtmv1rXXo
November 18th 2017, 2:11pm
emq_news @emq_news
New York State Common Retirement Fund Sells 1 Shares of Atara Biotherapeutics, Inc. $ATRA https://t.co/NkTjUJYHbF
November 18th 2017, 5:11am
TickerReport @TickerReport
New York State Common Retirement Fund Sells 1 Shares of Atara Biotherapeutics, Inc. $ATRA https://t.co/9rBxn5bDDB
November 18th 2017, 5:11am
TickerReport @TickerReport
New York State Common Retirement Fund Sells 1 Shares of Atara Biotherapeutics, Inc. $ATRA https://t.co/0iymYLiOWv
November 18th 2017, 5:11am
intercooleronli @intercooleronli
Christopher Haqq Sells 1,604 Shares of Atara Biotherapeutics, Inc. $ATRA Stock https://t.co/3LbRdNcmcv
November 17th 2017, 10:11pm
ConsumerFeed @ConsumerFeed
Christopher Haqq Sells 1,604 Shares of Atara Biotherapeutics, Inc. $ATRA Stock https://t.co/ErCFCSovKg #acn
November 17th 2017, 9:11pm
1MinuteStock @1MinuteStock
Do you know that #WallStreet price for $ATRA is $28.2 https://t.co/1WaV1lIsim
November 17th 2017, 9:11pm
AmericanBanking @AmericanBanking
Christopher Haqq Sells 1,604 Shares of Atara Biotherapeutics, Inc. $ATRA Stock https://t.co/SvfEJnweqy
November 17th 2017, 9:11pm
CFinancialNews @CFinancialNews
Christopher Haqq Sells 1,604 Shares of Atara Biotherapeutics, Inc. $ATRA Stock https://t.co/wGkDoJ6Aih
November 17th 2017, 9:11pm
1MinuteStock @1MinuteStock
We calculated 21-day Expected Return of $ATRA for you: 3.04% https://t.co/mmMRvxwNak
November 17th 2017, 9:11pm
1MinuteStock @1MinuteStock
Wondering about #sentiment indicator for $ATRA? The Short Ratio is 19.04% https://t.co/qKDkRBQGRj
November 17th 2017, 9:11pm
CFinancialNews @CFinancialNews
Gad Soffer Sells 7,000 Shares of Atara Biotherapeutics, Inc. $ATRA Stock https://t.co/PTd1MeyDJO
November 17th 2017, 9:11pm
WatchlistN @WatchlistN
Gad Soffer Sells 7,000 Shares of Atara Biotherapeutics, Inc. $ATRA Stock https://t.co/m0HeCj3VQT
November 17th 2017, 9:11pm
AmericanBanking @AmericanBanking
Gad Soffer Sells 7,000 Shares of Atara Biotherapeutics, Inc. $ATRA Stock https://t.co/lC8KDh5U9n
November 17th 2017, 9:11pm
intercooleronli @intercooleronli
Gad Soffer Sells 7,000 Shares of Atara Biotherapeutics, Inc. $ATRA Stock https://t.co/2yTxHqiUIW
November 17th 2017, 9:11pm
ConsumerFeed @ConsumerFeed
Gad Soffer Sells 7,000 Shares of Atara Biotherapeutics, Inc. $ATRA Stock https://t.co/tDhcYkagwd #acn
November 17th 2017, 8:11pm
1MinuteStock @1MinuteStock
Wondering about risks of $ATRA? The 63-day volatility is 25.4% https://t.co/Pkahinci8t
November 17th 2017, 7:11pm
ConsumerFeed @ConsumerFeed
Atara Biotherapeutics EVP Christopher Haqq Sells $21,429.44 in $ATRA https://t.co/oVfNKsFnvq
November 17th 2017, 7:11pm
InsiderAlertsIA @InsiderAlertsIA
$ATRA: New Insider Filing on EVP, R&D & Chief Scientific Of CHRISTOPHER HAQQ: https://t.co/0rW1AjccvJ
November 17th 2017, 6:11pm
TheMarketsDaily @TheMarketsDaily
Atara Biotherapeutics, Inc. $ATRA CEO Sells $59,268.00 in Stock https://t.co/OxYHiL71YT
November 17th 2017, 10:11am
storminvestor @storminvestor
Isaac E. Ciechanover Sells 4,400 Shares of Atara Biotherapeutics, Inc. $ATRA Stock https://t.co/XEIfGEUJTV
November 16th 2017, 3:11pm
dispatchtribune @dispatchtribune
Analyzing Atara Biotherapeutics $ATRA and Aduro Biotech $ADRO https://t.co/LLVctd4F2q
November 16th 2017, 7:11am
IRAMarketReport @IRAMarketReport
Atara Biotherapeutics, Inc. $ATRA Stake Held by Nationwide Fund Advisors https://t.co/1WOWIyMMpA
November 16th 2017, 5:11am
chaffeybreeze @chaffeybreeze
Atara Biotherapeutics, Inc. $ATRA Stake Held by Nationwide Fund Advisors https://t.co/PyR3mlCnjh
November 16th 2017, 5:11am
storminvestor @storminvestor
Analyzing Atara Biotherapeutics $ATRA and Aduro Biotech $ADRO https://t.co/J4ibMlATGC
November 16th 2017, 1:11am
intercooleronli @intercooleronli
Analyzing Atara Biotherapeutics $ATRA and Aduro Biotech $ADRO https://t.co/hzH0SF5Yk4
November 16th 2017, 1:11am
CFinancialNews @CFinancialNews
Analyzing Atara Biotherapeutics $ATRA and Aduro Biotech $ADRO https://t.co/laJYWjzMOp
November 16th 2017, 1:11am
ConsumerFeed @ConsumerFeed
Analyzing Atara Biotherapeutics $ATRA and Aduro Biotech $ADRO https://t.co/vPBrAWghXL #acn
November 16th 2017, 1:11am
AmericanBanking @AmericanBanking
Analyzing Atara Biotherapeutics $ATRA and Aduro Biotech $ADRO https://t.co/JKNF85q5vo
November 16th 2017, 1:11am
SPNewsAnalysis @SPNewsAnalysis
Analyzing Atara Biotherapeutics $ATRA and Aduro Biotech $ADRO https://t.co/LLyZqXUoqG
November 16th 2017, 1:11am
TickerReport @TickerReport
Atara Biotherapeutics, Inc. $ATRA CEO Isaac E. Ciechanover Sells 4,400 Shares https://t.co/OqMoSRRjBY
November 15th 2017, 5:11pm
emq_news @emq_news
Atara Biotherapeutics, Inc. $ATRA CEO Isaac E. Ciechanover Sells 4,400 Shares https://t.co/m0WRHUXVuY
November 15th 2017, 5:11pm
TickerReport @TickerReport
Atara Biotherapeutics, Inc. $ATRA CEO Isaac E. Ciechanover Sells 4,400 Shares https://t.co/Tft7YcwV1f
November 15th 2017, 5:11pm
gelantonia @gelantonia
RT @JacobPlieth: $ATRA logic for Keytruda combo is that EBV upregulates PD-L1 #Jefferies17 https://t.co/ejB80HMA0a
November 15th 2017, 9:11am
cells_nnm @cells_nnm
RT @JacobPlieth: $ATRA says it will invest heavily in progressive MS project, especially manufacturing (it’s an autologous product) #Jeffer…
November 15th 2017, 9:11am
deankrauss @deankrauss
RT @JacobPlieth: Big change in $ATRA #Jefferies17 presentation vs previous years is major focus on MS https://t.co/W4eUH1LsBg
November 15th 2017, 7:11am
deankrauss @deankrauss
RT @JacobPlieth: $ATRA notes correlation between ATA190 efficacy (progressive MS) and T-cell reactivity to EBV #Jefferies17 https://t.co/Yb…
November 15th 2017, 7:11am
JacobPlieth @JacobPlieth
@MikeNGladstone TBH I still don’t understand the EBV connection, but agree, fascinating $ATRA
November 15th 2017, 6:11am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.